Prism-filter lenses

The combination of prismatic and medicinal filters in a single lens block addresses the limitations of existing visual rehabilitation methods by enhancing visual acuity and clarity, achieving substantial improvements in low vision and blindness through targeted stimulation and redirection of the visual field.

WO2024229543A1PCT designated stage expired Publication Date: 2024-11-14PEREIRA SANTOS RANNI
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
PCT/BR2024/050187
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-10
Filing Date
2024-05-07
Publication Date
2024-11-14

AI Technical Summary

Technical Problem

Current visual rehabilitation methods using prismatic and filtering lenses separately do not fully address the challenges of low vision and blindness, as they do not effectively combine to improve visual acuity and clarity, particularly in cases of irreversible retinal and optic nerve diseases.

Method used

Combining prismatic lenses with medicinal filters in a single lens block, which can include spherical and cylindrical lenses, to create prismatic filtering lenses that stimulate the retina and promote neuroplasticity, improving image clarity and visual acuity by redirecting and amplifying the residual visual field.

Benefits of technology

This combination results in significant gains in visual acuity, with improvements of up to 8 lines in distance vision and enhanced reading speed, promoting effective visual rehabilitation for patients with low vision and blindness due to congenital or acquired retinal and optic nerve diseases.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BR2024050187_14112024_PF_FP_ABST
    Figure BR2024050187_14112024_PF_FP_ABST
Patent Text Reader

Abstract

The present utility model relates to prism-filter lenses in the field of ophthalmological medicine, and more specifically to prism lenses combined and joined with medical filters, applied to spectacle frames or intraocular lenses, which allow selective absorption of the visible light spectrum, and can also be combined concomitantly with spherical or cylindrical lenses. The object of the patent enables visual rehabilitation therapy for patients with congenital and / or acquired retinal and optic nerve diseases, allowing them to see clearly, with a continuous gain in lines of sight over time. There may be variations in prism dioptre, spherical dioptre, cylindrical dioptre, and medical filter applied, suitable for each patient according to the diagnosis of the pathology identified during the ophthalmological examination, being joined together in a single block (prism lens with medical filter tinting, with or without the joining of spherical or cylindrical lenses), which will make up the lens.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] FILTERING PRISMATIC LENSES DESCRIPTION Field

[0001] This utility model is applicable to the field of ophthalmological medicine, and refers to a filtering prismatic lens applied to glasses, intraocular lenses or contact lenses, consisting of a block of prismatic lens with application of medical filter coloring, with the function of visual rehabilitation in patients with low vision and / or blindness due to irreversible etiologies, allowing them to see clearly with the use of the object. Fundamentals

[0002] Visual rehabilitation is an area of ​​medicine that provides optical resources and aids to help blind and low-vision patients achieve improvements in the quality and quantity of functional vision.

[0003] Visual rehabilitation aims to restore eye movement abnormalities, such as various forms of strabismus, with or without nystagmus (rapid, involuntary eyeball movement) and amblyopia (low vision without injury). Prismatic lenses and filter lenses are currently used separately for visual rehabilitation, alleviating vision difficulties but not completely resolving the problem.

[0004] Prismatic lenses are optical systems that disperse and deflect light. They are typically used to deflect light in different ways, depending on the needs of each user and the amount of compensation required. They shift the image and compensate for a residual visual field by magnifying the displayed image and shifting it toward the visual axis. They also allow for the alignment and strengthening of the extrinsic vision muscles, which are weakened and misaligned in low vision, thereby correcting diplopia, nystagmus, and ocular deviations.

[0005] Filter lenses are colored lenses that allow the passage of a specific wavelength. They are also called medical filters because they absorb part of the light spectrum and stimulate the photoreceptor cells of the retina, which are affected by various retinal diseases. Filter lenses lead to greater visual resolution by reducing glare or increasing contrast sensitivity, providing the patient with greater visual comfort and image clarity. There are ocular conditions in which the selective absorption of the visible spectrum of light improves visual function, such as degenerative retinal diseases, neurological disorders, and decreased optical transparency.

[0006] The benefit of using these lenses separately in glasses is already widely recognized in the state of the art. However, this utility model patent concerns the possibility of combining prismatic lenses with medical filters in low vision, which allows for image shifting from the periphery to the center, according to the lateralization of the residual field of vision, amplifying this field and improving contrast, enabling better clarity and visual quality. This leads to a gain of 2 to 8 lines of vision in distance visual acuity tests, as well as improving near vision, enabling faster reading.

[0007] This utility model proposes combining prismatic lenses with medical filters, for use in eyeglass frames or as intraocular lenses or contact lenses. The prescription is performed using a trial frame with the lens blocks (prisms and medical filters) in question, with the possibility of combining them with spherical and cylindrical lenses (in some cases). The combination of medical filter lenses with prismatic lenses allows for an even more significant improvement in vision for people with low vision and / or blindness due to diseases of irreversible etiology (congenital and / or acquired diseases of the retina, optic nerve, and visual cortex).

[0008] Prismatic filter lenses are optical lenses composed of prisms tinted with medical filters, which may or may not include a combination of spherical and cylindrical lenses. The combination of prismatic lenses and the medical filter stimulates the retina and optical pathways, promoting neuroplasticity and possible cortical neuromodulation. This results in improved lines of vision and improved image clarity over time. They are a relevant optical aid for visual neurorehabilitation in low vision due to congenital and / or acquired retinal and optic nerve diseases. They consist of therapeutic lenses with cortical stimulation, promoting significant visual rehabilitation.

[0009] The prisms used in the utility model are graduated from 1 to 20 prism diopters, and the filters come in various colors (yellow, brown, red, orange, gray, green, and blue). The prism base will almost always be temporal, as it has been observed that the residual visual field in low vision is mostly located in the temporal part of the visual field, although it can also be located in the nasal and upper base.

[0010] In more advanced cases of blindness, prismatic lenses can have from 08 prismatic diopters with a temporal base or higher, together with medicinal filters (yellow, brown, red, orange, gray, green and blue) corresponding to the blocking of the specific light spectrum for each pathology causing low vision.

[0011] The ophthalmologist then, using medical test lenses and filters in the office, identifies the appropriate diopter, power, and filter for each patient. The prismatic lens is tested separately in each eye, in a trial frame, after the patient's refraction is performed in a refractor and the best correction is verified by measuring visual acuity. The examination is performed in a trial frame, with the Snellen optotype chart for distance and near readings. Thus, this utility model combines all the lenses and filters indicated for that patient in the appropriate positioning in a single object; several types of lenses are combined in a single block (spherical / cylindrical lenses + prism + medical filter tint).

[0012] The prismatic lens is selected based on the patient's low vision, and the prism base is always positioned at the site of residual vision (nasal, temporal, superior or inferior, and variations). In patients with absolute blindness (no residual vision), the prism is positioned according to the deviation of the extrinsic ocular muscles observed in these patients. Prisms with 1 to 20 prism diopters are used. The medical filters chosen to be combined with the prismatic lenses in trial frames are in the following colors, according to the diagnosed etiologies: brown, red, yellow, orange, green, blue, and gray.

[0013] Validation of the chosen combination and the improvement brought by the utility model can be done by measuring visual acuity, color testing, stereopsis testing, contrast sensitivity testing, visual field examination, electrophysiology study (visual evoked potential, PERG and PHNR).

[0014] Prismatic lenses and medical filters, considered individually, already exist and are in the state of the art; however, the lens resulting from the combination of lenses with these properties (filtering prismatic lens) in glasses, intraocular lenses or contact lenses is not found on the market or manufactured.

[0015] Thus, with regard to the state of the art, no artifact was found with the same technical characteristics as those used in this utility model capable of improving the solution to this problem of the state of the art, and therefore it meets the requirements of articles 9, 11 and 15 of the Industrial Property Law (Law No. 9,279 / 96). Description of the drawings

[0016] Figures 01 to 04 show the variations in prism positioning, showing the filtering prismatic lenses, respectively, with nasal base, temporal base, upper base and lower base.

[0017] Figures 5 to 11 show the same variations plus color variations (yellow, blue, gray, orange, brown, green, and red, respectively). Thus, each figure contains four columns of filtering prism lens pairs: the first representing nasal-based lenses, the second temporal-based lenses, the third superior-based lenses, and the fourth inferior-based lenses. Each figure also contains lines demonstrating the variations in hue of that color. Description

[0018] The filtering prismatic lenses, the subject of this utility model application, consist of a lens block, each composed of a prismatic lens tinted by the application of a medical filter, with the possibility of adding a cylindrical or spherical lens to each block. They can also be manufactured as intraocular lenses (PMMA or acrylic) or as contact lenses (rigid or hybrid). In short, they combine several types of specific lenses into a single block (spherical / cylindrical lenses + prism + application of medical filter tint), in a format not currently available on the market.

[0019] Those skilled in the art may, with the foregoing description, utilize this utility model in its broader context, manufacturing medical-grade filter prism glasses from a medical prescription, improving the process technique for assembling them into a single block. Any examples should be construed as merely illustrative and not as limiting the scope of this utility model in any way.

Claims

MODIFIED CLAIMS Received by the International Secretariat on 19 October 2024 (19.10.2024) 1. “FILTERING PRISMATIC LENSES” understood as a block of prismatic lens applied with a medicinal filter mounted on a spectacle frame, or made as an intraocular lens or contact lens, characterized by being composed of the combination and joining of a colored prismatic lens with a medicinal filter that provides selective absorption of the visible spectrum of light joined to the prismatic lens (between 01 and 20 prismatic diopters), made of ophthalmic resin in indexes of 1.499 or 1.67, surfaced with optical prisms, with the addition of medicinal filter treatment that can vary in frequencies from 20% to 80% of contrast or blocking of the visible spectrum (400 to 700 nanometers), according to the needs of each patient, and positioning according to the deviation of the extrinsic ocular muscles (nasal, temporal, superior or inferior, and variations).

2. “FILTERING PRISMATIC LENSES”, according to claim 1, characterized in that the lens is additionally composed of a spherical or cylindrical lens block.

3. “FILTERING PRISMATIC LENSES”, according to claims 1 and 2, characterized in that a medicinal filter has been used in its composition, in the colors brown (04 shades), red (04 shades), yellow (03 shades), orange (03 shades), green (03 shades), blue (03 shades), lilac (02 shades), pink (02 shades) and gray (03 shades).

4. “FILTERING PRISMATIC LENSES”, according to claims 1, 2 and 3, characterized in that the medicinal filter acts to reduce glare or increase contrast sensitivity.

5. “FILTERING PRISMATIC LENSES”, according to claims 1, 2 and 3, characterized in that a specific composition process was used for the joining of the described lens blocks, with the production of the colored prismatic lens using a medicinal resin filter with a refractive index between 1.499 or 1.

67.

6. “FILTERING PRISMATIC LENSES”, according to claims 1, 2 or 3, characterized by having been applied in the manufacture of contact lenses (rigid gas permeable with color), intraocular lenses (PMMA and hydrophilic with color) or resin lenses for spectacle frames. Declaration under Article 19(1) The written opinion of the international authority concluded that claims 1-6 are devoid of novelty. Therefore, claim 1 was amended, which impacts all other claims dependent on it, and claims 3, 5 and 6 were amended. The additions in claim 1 consisted of deepening the inventive act in relation to the state of the art, specifying contrast variation and blocking of the visible spectrum by adding medicinal filters, through a form not seen previously (manufacturing in optical resin with specific indexes of 1,499 or 1,670, coated with optical prisms). The specific characterization of the ophthalmic resin prismatic lens with indices of 1.499 or 1.670 was not known and provides a consistent improvement in contrast variation or spectrum blocking between frequencies of 20% to 80%, which was not part of the state of the art according to the literature indicated in the written opinion of the international authority. A prismatic lens is manufactured according to the orientation of the prism base, which must be specified in the optical prescription and can be superior, inferior, temporal, or nasal. Prismatic force is the refractive power of the lens, determined by the angle formed by the two surfaces of the lens and the refractive index. To obtain prismatic correction, it is possible to offset spherical lenses, provided the dioptric power is high or the need for prismatic effects is low. The refractive index of a prism is defined and consists of a characteristic of the transparent material that composes it. Refractive index is a dimensionless quantity that measures the relationship between the speed of light in different media. The shorter the wavelength of light, the higher the refractive index for a given medium. Medical filters are highly precise colorations that block certain parts of the spectrum from reaching the eye, thus improving the patient's visual comfort and contrast. There are several medical filters available, each with its own specific function of blocking the passage of a certain portion of the spectrum. The patient will choose the ideal color and tone from pre-selected samples based on transmittance. The amendment to claim 3 adds the possible hues for each medical filter color. The filtering prismatic lens or colored prismatic lens with a medicinal filter consists of the coloring of the prismatic lens, with alternating transmittance (400 to 700 nanometers), and specific blocking of the light spectrum, and may have the association of a spherical and / or cylindrical lens in the same composition block (filtering spherical-prismatic lens or filtering spherical-cylindrical prismatic lens or filtering cylindrical prismatic lens) with a refractive index alternating between 1.499 and 1.

67. This combination of the specific form described, by composition process specified in claim 5 as amended, did not previously exist in the state of the art, being an inventive act, including when applied to contact lenses (rigid gas permeable with color), intraocular lenses (PMMA and hydrophilic with color) or resin lenses for spectacle frames, as specified in claim 6 as amended.

Citation Information

Patent Citations

  • Optical filters affecting color vision in a desired manner and design method thereof by non-linear optimization

    US10606101B2

  • Eyewear with chroma enhancement

    US11099408B2

  • Ophthalmic devices having a highly selective violet light transmissive filter and related methods

    US8292428B2

  • Ophthalmic filter

    WO2013084178A1

  • Method for determining an ophthalmic lens and associated ophthalmic lens

    WO2018083038A1